Since MECP2 gene mutation was discovered to be the underlying cause of RTT [16,17] and its association with other neurodevelopmental disorders such as Angelman syndrome, FASD, MDS, and ASD [109], a connection was made evident between MeCP2 and brain function. This evidence concerns the gene MECP2 and Angelman syndrome.